NFKB1 and acute myeloid leukemia: To determine whether inhibition of NF-κB could delay the over-proliferation of PHF6 OE AML cells, we treated PHF6 OE myeloid leukemia cells with BAY11-7082 (a selective NF-κB inhibitor).